Telomeres, telomerase and cancer: An up-date

Virchows Archiv

Volumn 437, Issue 1, 2000, Pages 1-16

  Dhaene, Karl ^a   Van Marck, Eric ^a   Parwaresch, Reza ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Cancer; Telomerase; Telomeres

Indexed keywords

RIBONUCLEOPROTEIN; TELOMERASE; TUMOR MARKER;

CANCER GENETICS; CELL PROLIFERATION; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TELOMERE; THEORY; TUMOR GROWTH;

AGING; ANIMALS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOPLASMS; TELOMERASE; TELOMERE; TRANSFECTION;

EID: 0033945105     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000189     Document Type: Review

References (125)

1. 1. Aldous WK, Grabill NR (1997) A fluorescent method for detection of telomerase activity. Diagn Mol Pathol 6:102-110
2. 2. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider C, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 89:10114-10118
3. 3. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW (1996) Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650
4. 4. Bechter OE, Eisterer W, Pall G, Hilbe W, Kühr T, Thaler J (1998) Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 58:4918-4922
5. 5. Belair CD, Yeager TR, Lopez PM, Reznikoff CA (1997) Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci U S A 94: 13677-13682
6. 6. Bickenbach JR, Vornwald D, V, Bachor C, Bleuel K, Schnapp G, Boukamp P (1998) Telomerase is not an epidermal stem cell marker and is downregulated by calcium. J Invest Dermatol 111:1045-1052
7. 7. Blasco MA, Rizen M, Greider CW, Hanahan D (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12:200-204
8. 8. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34
9. 9. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352
10. 10. Bonatz G, Klapper W, Barthe A, Heidorn K, Jonat W, Krupp G, Parwaresch R (1998) Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium. Biochem Biophys Res Commun 253:214-221
11. 11. Bond JA, Wyllie FS, Wynford-Thomas D (1994) Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885-1889
12. 12. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumours and tumour-derived cell lines. Nat Med 3:1271-1274
13. 13. Bryant JE, Hutchings KG, Moyzis RK, Griffith JK (1997) Measurement of telomeric DNA content in human tissues. Biotechniques 23:476-483
14. 14. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider C, DePinho R (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97:527-538
15. 15. Cong YS, Wen JP, Bacchetti S (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8:137-142
16. 16. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929
17. 17. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalisation. Proc Natl Acad Sci U S A 95: 14723-14728
18. 18. Dahse R, Fiedler F, Ernst G, Kosmehl H, Schlichter A, Schubert J, Claussen U (1996) Changes in telomere lengths in renal cell carcinomas. Cell Mol Biol 42:477-485
19. 19. Dhaene K, Hübner R, Kumar-Singh S, Weyn B, Van Marck E (1998) Telomerase activity in human pleural mesothelioma. Thorax 53:915-918
20. 20. Dhaene K, Vancoillie G, Lambert J, Naeyaert JM, Van Marck E (2000) Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures. Br J Cancer 82:1051-1057
21. 21. Dhaene K, Wauters J, Weyn B, Timmermans JP, Van Marck E (2000) Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 190:80-85
22. 22. Eickbush TH (1997) Telomerase and retrotransposons: which came first? Science 277:911-912
23. 23. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider C, Villeponteau B (1995) The RNA component of human telomerase. Science 269: 1236-1241
24. 24. Fong D, Burke JP, Chan MM (1997) Nonradioactive, agarose minigel procedure for telomeric amplification protocol. Biotechniques 23:1029-1032
25. Δ2/3 cancer-prone mouse. Cell 97:515-525
26. 26. Greider CW (1998) Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A 95:90-92
27. 27. Griffith JK, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, De Lange T (1999) Mamalian telomeres end in a large duplex loop. Cell 97:503-514
28. 28. Halvorsen TL, Leibowitz G, Levine F (1999) Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 19:1864-1870
29. 29. Hande MP, Samper E, Lansdorp PM, Blasco MA (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 144:589-601
30. 30. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW (1994) Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59:307-315
31. 31. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program, Bass MB, Arruda I, Robinson MO (1997) A mammalian telomerase-associated protein. Science 275:973-977
32. 32. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB, Robinson MO (1997) Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11:3109-3115
33. 33. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature 346:866-868
34. 34. Heine B, Hummel M, Demel G, Stein H (1998) Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization. J Pathol 185:139-144
35. 35. Herrera E, Samper E, Blasco MA (1999) Telomere shortening in mTR-/-embryos is associated with failure to close the neural tube. EMBO J 18:1172-1181
36. 36. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N (1998) Telomerase activity and alterations in telomere length in human brain tumours. Cancer Res 58:2117-2125
37. 37. Hiyama E, Hiyama K, Yokoyama Y, Ichikawa T, Matsuura Y (1992) Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 83:159-164
38. 38. Hiyama T, Yokozaki H, Kitadai Y, Tahara E, Tahara H, Ide T, Haruma K, Yasui W, Kajiyama G (1998) In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions. Jpn J Cancer Res 89:1187-1194
39. 39. Horikawa I, Cable PL, Afshari C, Barrett JC (1999) Cloning and characterisation of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59:826-830
40. 40. Horvath MP, Schweiker VL, Bevilacqua JM, Ruggles JA, Schultz SC (1998) Crystal structure of the Oxytricha nova telomere end binding protein complexed with single strand DNA. Cell 95:963-974
41. 41. Hsu H, Gilley D, Blackburn EH, Chen DJ (1999) Ku is associated with the telomere in mammals. Proc Natl Acad Sci U S A 96:12454-12458
42. 42. Hultdin M, Gronlund E, Norrback KF, Eriksson-Lindstrom E, Just T, Roos G (1998) Telomere analysis by fluorescence in situ hybridisation and flow cytometry. Nucleic Acids Res 26:3651-3656
43. 43. Ito H, Kyo S, Kanaya T, Takakura M, Inoue M, Namiki M (1998) Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 4:1603-1608
44. 44. Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Kawakubo K, Shay JW, Toyama K (1997) The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer 79:1552-1560
45. 45. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-114
46. 46. Jirikowski GF (1999) Histochemical visualisation of telomerase activity (abstract). Proceedings of the 6th International Conference and Workshops on Molecular Morphology, 5-9 October, 1998, Salzburg, Austria. Appl Immunohistochem Mol Morphol 7:89-102
47. 47. Kanaya T, Kyo S, Takakura M, Ito H, Namiki M, Inoue M (1998) hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int J Cancer 78:539-543
48. 48. Kickhoefer VA, Stephen AG, Harrington L, Robinson MO, Rome LH (1999) Vaults and telomerase share a common subunit, TEP1. J Biol Chem 274:32712-32717
49. 49. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019
50. 50. Kim NW, Wu F (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25:2595-2597
51. 51. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015
52. 52. Kim S, Kaminker P, Campisi J (1999) TIN2, a new regulator of telomere length in human cells. Nat Genet 23:405-412
53. 53. Kinoshita H, Ogawa O, Mitsumori K, Kakehi Y, Terachi T, Yoshida O (1998) Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. J Urol 159:245-251
54. 54. Kipling D (ed) (1995) The telomere. Oxford University Press, Oxford
55. 55. Kipling D (1997) Mammalian telomerase: catalytic subunit and knockout mice. Hum Mol Genet 6:1999-2004
56. 56. Klapper W, Singh KK, Heidorn K, Parwaresch R, Krupp G (1998) Regulation of telomerase activity in quiescent immortalized human cells. Biochem Biophys Acta 1442:120-126
57. 57. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL (1998) Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 19:182-186
58. 58. Krupp G, Kühne K, Tamm S, Klapper W, Heidorn K, Rott A, Parwaresch R (1997) Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay. Nucleic Acids Res 25:919-921
59. 59. Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K (1998) Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82:176-179
60. 60. Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M (1999) Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer 80:60-63
61. 61. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, Inoue M (1999) Expression of human telomerase subunits in ovarian malignant borderline and benign tumors. Int J Cancer 80:804-809
62. 62. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M (1999) Estrogen activates telomerase. Cancer Res 59:5917-5921
63. 63. Lansdorp PM (1997) Lessons from mice without telomerase. J Cell Biol 139:309-312
64. 64. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-574
65. 65. Li H, Zhao LL, Yang ZY, Funder JW, Liu JP (1998) Telomerase is controlled by protein kinase C alpha in human breast cancer cells. J Biol Chem 273:33436-33442
66. 66. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF (1999) The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85:741-749
67. 67. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK, Lansdorp PM (1998) Short telomeres on human chromosome 17p. Nat Genet 18:76-80
68. 68. Martin RL, Herrera E, Albar JP, Blasco MA (1998) Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci U S A 95:10471-10476
69. 69. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu QY, Bacchetti S, Haber DA, Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795
70. 70. Mitchell JR, Cheng J, Collins K (1999) A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol 19:567-576
71. 71. Morales CP, Lee EL, Shay JW (1998) In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 83: 652-659
72. 72. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 21:115-118
73. 73. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959
74. 74. Nakano K, Watney E, McDougall JK (1998) Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol 153:857-864
75. 75. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88:875-884
76. 76. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Ide T, Ishikawa F (1998) Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18:65-68
77. 77. Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y, Shinkai Y (1998) Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet 19:203-206
78. 78. Nugent CI, Hughes TR, Lue NF, Lundblad V (1996) Cdc13p: a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science 274:249-252
79. 79. Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H (1994) Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 73:2978-2984
80. 80. Ogoshi M, Le T, Shay JW, Taylor RS (1998) In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 110:818-823
81. 81. Ohyashiki JH, Iwama H, Yahata N, Ando K, Hayashi S, Shay JW, Ohyashiki K (1999) Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clin Cancer Res 5:1155-1160
82. 82. Ohyashiki K, Ohyashiki JH, Nishimaki J, Toyama K, Ebihara Y, Kato H, Wright WE, Shay JW (1997) Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 57:2100-2103
83. 83. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R (1998) Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res 58:622-625
84. 84. Ricchetti M, Buc H (1997) Telomerase activity of reverse transcriptase. Science 277:887
85. 85. Rudolph KL, Chang S, Lee HW, Blasco MA, Gottlieb GJ, Greider C, DePinho R (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-712
86. 86. Rudolph P, Lappe T, Hero B, Parwaresch R, Harms D, Schmidt D (1997) Prognostic significance of the proliferative activity in neuroblastoma. Am J Pathol 150:133-145
87. 87. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J (1997) Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 150:1159-1164
88. 88. Shay JW (1999) Toward identifying a cellular determinant of telomerase repression. J Natl Cancer Inst 91:4-6
89. 89. Shay JW, Brasiskyte D, Quelette M (1994) Analysis of telomerase and telomeres. Methods Mol Genet 5:263-268
90. 90. Shay JW, Werbin H, Wright WE (1996) Telomeres and telomerase in human leukemias. Leukemia 10:1255-1261
91. 91. Shirotani Y, Hiyama K, Ishioka S, Inyaku K, Awaya Y, Yonehara S, Yoshida Y, Inai K, Hiyama E, Hasegawa K (1994) Alteration in length of telomeric repeats in lung cancer. Lung Cancer 11:29-41
92. 92. Smith S, De Lange T (1997) TRF1, a mammalian telomeric protein. Trends Genet 13:21-26
93. 93. Smith S, De Lange T (1999) Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Science 112:3649-3656
94. 94. Smith S, Giriat I, Schmitt A, De Lange T (1998) Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282:1484-1487
95. 95. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN (1997) Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14:1013-1021
96. 96. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N (1999) Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer 80:1-4
97. 97. Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, Nakayama J, Ishikawa F, Ide T (1999) Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18:1561-1567
98. 98. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M (1998) Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 58:1558-1561
99. 99. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557
100. 100. Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, Omine M, Ishikawa F (1996) A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 13:2265-2274
101. 101. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168-4172
102. 102. Van Steensel B, Smogorzewska A, De Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413
103. 103. Vaziri H, Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8:279-282
104. 104. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros RB, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661-667
105. 105. Wainwright J, Middleton PG, Rees JL (1995) Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosomes Cancer 12:45-49
106. 106. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17:498-502
107. 107. Wen JM, Sun LB, Zhang M, Zheng MH (1998) A non-isotopic method for the detection of telomerase activity in tumour tissues: TRAP-silver staining assay. J Clin Pathol Mol Pathol 51:110-112
108. 108. Wick M, Zubov D, Hagen G (1999) Genomic organisation and promoter characterisation of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106
109. 109. Wright WE, Shay JW (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27:383-389
110. 110. Wright WE, Pereira SO, Shay JW (1989) Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9:3088-3092
111. 111. Wright WE, Shay JW, Piatyszek MA (1995) Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23:3794-3795
112. 112. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-Myc. Nat Genet 21:220-224
113. 113. Wynford-Thomas D (1999) Cellular senescence and cancer. J Pathol 187:100-111
114. 114. Wynford-Thomas D, Kipling D (1997) Telomerase. Cancer and the knockout mouse. Nature 389:551-552
115. 115. Xu DW, Gruber A, Peterson C, Pisa P (1998) Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol 102:1367-1375
116. 116. Yang JY, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar AG, Bronstein A, Chiu CP, Herron GS (1999) Human endothelial cell life extension by telomerase expression. J Biol Chem 274:26141-26148
117. 117. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, Milchgrub S, Srivastava S, Piatyszek MA, Shay JW, Gazdar AF (1997) Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 57:2373-2377
118. 118. Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, Gazdar AF (1997) Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 50:110-117
119. 119. Yashima K, Ashfaq R, Nowak J, Von Gruenigen V, Milchgrub S, Rathi A, Albores Saavedra J, Shay JW, Gazdar AF (1998) Telomerase activity and expression of its RNA component in cervical lesions. Cancer 82:1319-1327
120. 120. Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW, Gazdar AF (1998) Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 4:229-234
121. 121. Yasui W, Tahara H, Tahara E, Fujimoto J, Nakayama J, Ishikawa F, Ide T (1998) Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn J Cancer Res 89:1099-1103
122. 122. Yuan X, Ishibashi S, Hatakeyama S, Saito M, Nakayama J, Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida H, Sugimura H, Yamada N, Ishikawa F (1999) Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells 4:563-572
123. 123. Zakian VA (1997) Life and cancer without telomerase. Cell 91:1-3
124. 124. Zhao JQ, Hoare SF, McFarlane R, Muir S, Parkinson EK, Black DM, Keith WN (1998) Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 16:1345-1350
125. 125. Zhu L, Smith S, De Lange T, Seldin MF (1999) Chromosomal mapping of the tankyrase gene in human and mouse. Genomics 57:320-321